CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,000 | -38.5% | 13,950 | -3.3% | 0.01% | -33.3% |
| Q2 2022 | $26,000 | -10.3% | 14,424 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $29,000 | -29.3% | 14,424 | -4.5% | 0.01% | -25.0% |
| Q4 2021 | $41,000 | -42.3% | 15,099 | -4.7% | 0.02% | -51.5% |
| Q3 2021 | $71,000 | -22.8% | 15,849 | 0.0% | 0.03% | -21.4% |
| Q2 2021 | $92,000 | -17.1% | 15,849 | 0.0% | 0.04% | -48.1% |
| Q1 2021 | $111,000 | +46.1% | 15,849 | 0.0% | 0.08% | +97.6% |
| Q4 2020 | $76,000 | – | 15,849 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $14,259,560,000 | 8.34% |
| Palo Alto Investors LP | 3,547,719 | $124,170,000 | 6.91% |
| Antipodean Advisors LLC | 1,268,658 | $44,403,000 | 6.48% |
| Redmile Group, LLC | 1,795,936 | $62,858,000 | 4.70% |
| HealthCor Management, L.P. | 1,525,000 | $53,375,000 | 3.24% |
| PointState Capital LP | 3,503,900 | $122,637,000 | 3.12% |
| NEA Management Company, LLC | 1,139,890 | $39,896,000 | 2.54% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 612,500 | $21,438,000 | 2.44% |
| PFM Health Sciences, LP | 2,078,440 | $72,745,000 | 2.21% |
| Partner Investment Management, L.P. | 35,300 | $1,236,000 | 2.03% |